Non-Opioid Analgesics & Antipyretics Questions
Order by
36 terms
Terms | Definitions |
|---|---|
4 major actions of NSAID's | anti-inflammatory, analgesic, antipyretic, antiplatelet |
MOA of NSAID anti-inflammatory effect | decr in vasodilatory PGs results, indirectly, in decreased edema; accumulation of inflammatory cells is not reduced significantly |
MOA of NSAID analgesic effect | decr PGs mean less sensitization of nociceptive nerve endings to mediators (aka- bradykinin and 5-HT) |
MOA of NSAID antipyretic effect | centrally mediated, partly the result of decr in PG response to cytokines (e.g. IL-1) |
MOA of NSAID antiplatelet effect | most NSAIDs induce reversible inhibition of thromboxane synthesis; aspirin's axn however is irreversible |
Effects of NSAIDs on PG synthesis | inhibit COX enzyme which gives rise to biosynthesis of PG which cause pain |
Adverse Rxns to NSAIDs | GI ulceration, renal injury, increased CV risk |
Adverse Rxn to COX-2 Inhibitors | CV: pot'l for MI, hypertension, edema; CNS: headache, fever; GI: diarrhea, nausea; Respiratory: upper respiratory tract infection, cough |
Toxic effects of NSAIDs | GI bleeding (pot'l fatal), renal insufficiency, incr risk of CV disease, & poss drug-drug interaxn from high plasma prot. Binding; most serious- result from intentional overdose or excess ethanol ingestion |
Use of acetaminophen | Tx fever and pain |
Importance of DMARDs | can alter the course of rheumatic disorders, such as RA |
Inflammation signs | Heat, Redness, Swelling, Pain, and maybe LoF |
Mxn of heat response | Vasodilation |
Mxn of redness response | Vasodilation |
Mxn of swelling response | incr vascular permeability, incr granulation tissue |
Mxn of pain response | physical and chemical stimulation of nociceptors |
Mxn of LoF response | pain; reflex muscle inhibition; disruption of tissue structure |
Histamine's effects | increases vasc permeability, promotes vasodilation |
Bradykinin's effects | vasodilatory, vascular permeability, pain |
Mediators of Acute inflammation | histamine, bradykinin, prostaglandins, leukotrienes |
Prostaglandins' effects | do it all- promote vasodilation, increase vascular permeability, chemotaxis, some induction of pain response |
Leukotrienes effects | very potent chemoattractants, more impt in allergic rxns |
Mediators of Chronic inflammation | IL-1, TNFalpha, IL-6, IL-2, IFN (I&II), chemokines |
IL-1 activities | induces lymphocyte activation, mediator induction, monocyte/macrophage activation, induce prostaglandins (PGs) |
TNF alpha activities | mediator induction, monocyte/macrophage activation, PGs |
IL-6 activities | Mediator induction, monocyte/macrophage differentiation, fever |
IL-2 activities | potent lymphocyte activator and differentiator, mediator induction |
IFN (I&II) activities | monocyte/macrophage activation, cytotoxic lymphocyte activation; antimicrobial activity |
Chemokines activities | Chemoattractants |
NSAIDs activities | anti-inflammatory, analgesic, anti-pyretic |
NSAIDs common mxn | affect arachidonic acid metabolism; block COX |
DoA of COX inhibitors is primarily related to | pharmacokinetic clearance of the drug from the body, all are reversible except aspirin |
COX-1 | expressed in most tissues, constitutively active, necessary for cytoprotection in GI tract |
COX-2 | believed to be enzyme that produces the prostanoid mediators of inflammation, induced in inflammatory cells |
COX inhibitors MoA | inhibition of COX in immune system |
______ is a very important target for RA | TNF alpha |
First Time Here?
Welcome to Quizlet, a fun, free place to study. Try these flashcards, find others to study, or make your own.